IL153279A0 - Thiazolidinedione salt for treatment of diabetes mellitus - Google Patents
Thiazolidinedione salt for treatment of diabetes mellitusInfo
- Publication number
- IL153279A0 IL153279A0 IL15327901A IL15327901A IL153279A0 IL 153279 A0 IL153279 A0 IL 153279A0 IL 15327901 A IL15327901 A IL 15327901A IL 15327901 A IL15327901 A IL 15327901A IL 153279 A0 IL153279 A0 IL 153279A0
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- diabetes mellitus
- thiazolidinedione
- salt
- thiazolidinedione salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0014006.1A GB0014006D0 (en) | 2000-06-08 | 2000-06-08 | Novel pharmaceutical |
| PCT/GB2001/002567 WO2001094344A1 (en) | 2000-06-08 | 2001-06-08 | Thiazolidinedione salt for treatment of diabetes mellitus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL153279A0 true IL153279A0 (en) | 2003-07-06 |
Family
ID=9893257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15327901A IL153279A0 (en) | 2000-06-08 | 2001-06-08 | Thiazolidinedione salt for treatment of diabetes mellitus |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1296980A1 (sk) |
| JP (1) | JP2003535862A (sk) |
| KR (1) | KR20030007918A (sk) |
| CN (1) | CN1443186A (sk) |
| AP (1) | AP2002002673A0 (sk) |
| AU (1) | AU2001264078A1 (sk) |
| BG (1) | BG107357A (sk) |
| BR (1) | BR0111536A (sk) |
| CA (1) | CA2411065A1 (sk) |
| CZ (1) | CZ20023966A3 (sk) |
| DZ (1) | DZ3382A1 (sk) |
| EA (1) | EA200300005A1 (sk) |
| GB (1) | GB0014006D0 (sk) |
| HU (1) | HUP0301137A3 (sk) |
| IL (1) | IL153279A0 (sk) |
| MA (1) | MA25753A1 (sk) |
| MX (1) | MXPA02012100A (sk) |
| NO (1) | NO20025883L (sk) |
| OA (1) | OA12284A (sk) |
| PL (1) | PL360592A1 (sk) |
| SK (1) | SK17142002A3 (sk) |
| WO (1) | WO2001094344A1 (sk) |
| ZA (1) | ZA200209954B (sk) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE39384E1 (en) | 1993-09-01 | 2006-11-07 | Smithkline Beecham P.L.C. | Substituted thiazolidinedione derivatives |
| DE102005034406A1 (de) * | 2005-07-22 | 2007-02-01 | Ratiopharm Gmbh | Neue Salze von Rosiglitazon |
| WO2008091624A2 (en) * | 2007-01-22 | 2008-07-31 | Teva Pharmaceutical Industries Ltd. | Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof |
| EP1956018A1 (de) * | 2007-02-06 | 2008-08-13 | Boehringer Ingelheim Pharma GmbH & Co. KG | Verfahren zur Herstellung eines Benzimidazolderivats |
| WO2010021745A2 (en) * | 2008-08-21 | 2010-02-25 | Teva Pharmaceutical Industries Ltd. | Polymorphic forms of rosiglitazone hydrobromide and processes for their preparation |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
-
2000
- 2000-06-08 GB GBGB0014006.1A patent/GB0014006D0/en not_active Ceased
-
2001
- 2001-06-08 CN CN01813190A patent/CN1443186A/zh active Pending
- 2001-06-08 DZ DZ013382A patent/DZ3382A1/xx active
- 2001-06-08 JP JP2002501893A patent/JP2003535862A/ja active Pending
- 2001-06-08 CZ CZ20023966A patent/CZ20023966A3/cs unknown
- 2001-06-08 HU HU0301137A patent/HUP0301137A3/hu unknown
- 2001-06-08 MX MXPA02012100A patent/MXPA02012100A/es unknown
- 2001-06-08 BR BR0111536-7A patent/BR0111536A/pt not_active IP Right Cessation
- 2001-06-08 SK SK1714-2002A patent/SK17142002A3/sk not_active Application Discontinuation
- 2001-06-08 KR KR1020027016721A patent/KR20030007918A/ko not_active Application Discontinuation
- 2001-06-08 OA OA1200200370A patent/OA12284A/en unknown
- 2001-06-08 CA CA002411065A patent/CA2411065A1/en not_active Abandoned
- 2001-06-08 IL IL15327901A patent/IL153279A0/xx unknown
- 2001-06-08 EP EP01938400A patent/EP1296980A1/en not_active Withdrawn
- 2001-06-08 AP APAP/P/2002/002673A patent/AP2002002673A0/en unknown
- 2001-06-08 WO PCT/GB2001/002567 patent/WO2001094344A1/en not_active Application Discontinuation
- 2001-06-08 EA EA200300005A patent/EA200300005A1/ru unknown
- 2001-06-08 PL PL36059201A patent/PL360592A1/xx not_active Application Discontinuation
- 2001-06-08 AU AU2001264078A patent/AU2001264078A1/en not_active Abandoned
-
2002
- 2002-12-04 MA MA26933A patent/MA25753A1/fr unknown
- 2002-12-05 BG BG107357A patent/BG107357A/bg unknown
- 2002-12-06 NO NO20025883A patent/NO20025883L/no not_active Application Discontinuation
- 2002-12-09 ZA ZA200209954A patent/ZA200209954B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001264078A1 (en) | 2001-12-17 |
| EP1296980A1 (en) | 2003-04-02 |
| CZ20023966A3 (cs) | 2003-04-16 |
| AP2002002673A0 (en) | 2002-12-31 |
| DZ3382A1 (fr) | 2001-12-13 |
| HUP0301137A3 (en) | 2005-04-28 |
| EA200300005A1 (ru) | 2003-04-24 |
| JP2003535862A (ja) | 2003-12-02 |
| BG107357A (bg) | 2003-08-29 |
| KR20030007918A (ko) | 2003-01-23 |
| NO20025883D0 (no) | 2002-12-06 |
| MA25753A1 (fr) | 2003-04-01 |
| CA2411065A1 (en) | 2001-12-13 |
| GB0014006D0 (en) | 2000-08-02 |
| HUP0301137A2 (hu) | 2003-08-28 |
| BR0111536A (pt) | 2003-07-01 |
| ZA200209954B (en) | 2003-10-10 |
| PL360592A1 (en) | 2004-09-20 |
| OA12284A (en) | 2003-11-10 |
| MXPA02012100A (es) | 2003-04-25 |
| CN1443186A (zh) | 2003-09-17 |
| SK17142002A3 (sk) | 2003-10-07 |
| NO20025883L (no) | 2003-02-03 |
| WO2001094344A1 (en) | 2001-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL370818A1 (en) | Dosage form for treatment of diabetes mellitus | |
| MXPA03006936A (es) | Tratamiento de diabetes mellitus. | |
| EG24124A (en) | Pharmaceutical compositions for the treatment of type-II diabetes mellitus | |
| IL160884A0 (en) | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease | |
| IL147822A0 (en) | Benzoic acid derivatives for the treatment of diabetes mellitus | |
| AU2001282873A1 (en) | Quinuclidine-substituted aryl compounds for treatment of disease | |
| HK1087103A1 (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| AU2001284645A1 (en) | Quinuclidine-substituted aryl compounds for treatment of disease | |
| IL138784A0 (en) | Treatment for diabetes | |
| AU2000276362A1 (en) | Composition for the treatment of diabetes | |
| AU2003279442A8 (en) | 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes | |
| HUP0401612A3 (en) | Pharmaceutical composition suitable for treating diabetes | |
| IL153279A0 (en) | Thiazolidinedione salt for treatment of diabetes mellitus | |
| IL162853A0 (en) | The use of melagatran for the manufacture of a medicament for the treatment of type 1 diabetes mellitus | |
| AU2003260813A8 (en) | Improved process for preparation of thiazolidinedione derivatives | |
| HUP0300777A3 (en) | Tartrate salt of thiazolidinedione derivative | |
| EP1435962A4 (en) | TREATMENT OF DIABETES TYPE I | |
| GB2355189B (en) | Herbal preparation for the treatment of diabetes mellitus | |
| AU6478900A (en) | Novel use of angelan from angelica gigas for treating diabetes mellitus | |
| HK1057358A1 (en) | Tartrate salt of thiazolidinedione derivative | |
| GB0212790D0 (en) | Medicament for the treatment of diabetes | |
| GB0106468D0 (en) | Treatment of diabetes mellitus | |
| SI1383523T1 (sl) | Sredstvo za zdravljenje diabetes mellitusa | |
| AU2000272704A1 (en) | Use of compounds for the treatment of obesity | |
| HUP0300724A3 (en) | Tartrate salt of thiazolidinedione derivative |